Nuvilex's Medical Marijuana Subsidiary Poised for Growth in the New Year
03 janv. 2014 09h30 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jan 3, 2014) - Nuvilex, Inc. (OTCQB: NVLX) will be starting 2014 off with a flurry of activity inside its wholly owned subsidiary, Medical Marijuana Sciences, Inc....
Nuvilex Lands Leading Figure in Medical Marijuana Field as Chairman of Subsidiary's Scientific Advisory Board
23 déc. 2013 08h45 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Dec 23, 2013) - Nuvilex, Inc. (OTCQB: NVLX) upped the ante this month in the field of medical marijuana when it appointed Dr. Mark L. Rabe as Chairman of its...
Nuvilex to Answer Increasing Calls for Better Pancreatic Cancer Treatment Without Gemcitabine
16 déc. 2013 09h15 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Dec 16, 2013) - Nuvilex, Inc. (OTCQB: NVLX) may be just what the National Cancer Institute (NCI) and a growing number of doctors ordered - the company's late stage...
Nuvilex's Acquisition of Diabetes Rights Should Put the Company on Everyone's Radar
19 nov. 2013 08h30 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Nov 19, 2013) - Nuvilex, Inc. (OTCQB: NVLX) recently acquired the exclusive worldwide rights to a proprietary cellulose-based live-cell encapsulation technology for...
Investors Confidently Back Nuvilex's Acquisition of Diabetes Technology
12 nov. 2013 08h45 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Nov 12, 2013) - Nuvilex, Inc. (OTCQB: NVLX) announced last week that it has acquired the exclusive worldwide rights to a cellulose-based live-cell encapsulation...
Nuvilex, Inc. Reaches Unofficial Starting Line of Its Phase 3 Pancreatic Cancer Clinical Trials
05 nov. 2013 08h30 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Nov 5, 2013) - Nuvilex, Inc. (OTCQB: NVLX) made an announcement yesterday that should have investors excited that the company's Phase 3 clinical trials may have...
Is Nuvilex Ready to Acquire Diabetes Technology and Control Cancer and Diabetes Cell Encapsulation Markets?
01 nov. 2013 09h30 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Nov 1, 2013) - With October behind us, Nuvilex, Inc. (OTCQB: NVLX) investors should see a new acquisition this month. Two weeks ago Stock Market Media Group, a...
Nuvilex, Inc.'s COO, Dr. Gerald Crabtree, Interviews With Stock Market Media Group
17 oct. 2013 08h30 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Oct 17, 2013) - Nuvilex Inc.'s, (OTCQB: NVLX) Chief Operating Officer, Dr. Gerald Crabtree sat down for an interview with Stock Market Media Group, a research and...
Nuvilex, Inc.'s Marijuana Research Into Cannabidiol Could Lead to Many Successes
03 oct. 2013 10h00 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Oct 3, 2013) - Nuvilex, Inc. (OTCQB: NVLX) formed its subsidiary, Medical Marijuana Sciences, Inc., to study the medical applications of marijuana, and more...
Nuvilex, Inc. Names Two Significant Partners on Its Way to Phase 3 Clinical Trials
19 sept. 2013 09h00 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Sep 19, 2013) - Nuvilex, Inc. (OTCQB: NVLX) made another subtle but significant move this week that seems to signal the company is in "go-mode" on its future Phase III...